About Kevin Eisenfrats
Kevin Eisenfrats is a co-founder and CEO, director at Contraline.
Kevin Eisenfrats first appears on SEC filings in 2022.
Experience
This experience comes from Kevin Eisenfrats's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kevin Eisenfrats in the role, so the role may have started earlier or lasted longer.
1V
13 Ventures Current
Investor
2017 – Present
Contraline, Inc. Current
Co-Founder and CEO, director
2015 – Present · Charlottesville, VA
Develops investigational contraceptive gel and implants for men.
UE
University of Virginia Department of Biomedical Engineering Current
Alumni Board (2023 – Present)
Researcher (2012 – 2015)
2012 – Present
TH
The National Institutes of Health
Researcher
2014
Key Colleagues at Startups
The people Kevin Eisenfrats works with at each company, as listed on that company's latest Form D.
Contraline, Inc. · Form D, Jun 10, 2026
